全文获取类型
收费全文 | 15573篇 |
免费 | 896篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 104篇 |
儿科学 | 303篇 |
妇产科学 | 237篇 |
基础医学 | 2197篇 |
口腔科学 | 585篇 |
临床医学 | 1160篇 |
内科学 | 3715篇 |
皮肤病学 | 379篇 |
神经病学 | 1195篇 |
特种医学 | 762篇 |
外科学 | 2235篇 |
综合类 | 70篇 |
预防医学 | 592篇 |
眼科学 | 328篇 |
药学 | 1078篇 |
中国医学 | 16篇 |
肿瘤学 | 1594篇 |
出版年
2023年 | 80篇 |
2021年 | 311篇 |
2020年 | 165篇 |
2019年 | 218篇 |
2018年 | 325篇 |
2017年 | 254篇 |
2016年 | 319篇 |
2015年 | 299篇 |
2014年 | 360篇 |
2013年 | 455篇 |
2012年 | 785篇 |
2011年 | 870篇 |
2010年 | 434篇 |
2009年 | 423篇 |
2008年 | 778篇 |
2007年 | 742篇 |
2006年 | 794篇 |
2005年 | 779篇 |
2004年 | 769篇 |
2003年 | 772篇 |
2002年 | 785篇 |
2001年 | 457篇 |
2000年 | 485篇 |
1999年 | 480篇 |
1998年 | 191篇 |
1997年 | 162篇 |
1996年 | 140篇 |
1995年 | 103篇 |
1994年 | 125篇 |
1993年 | 127篇 |
1992年 | 334篇 |
1991年 | 327篇 |
1990年 | 285篇 |
1989年 | 281篇 |
1988年 | 299篇 |
1987年 | 253篇 |
1986年 | 240篇 |
1985年 | 215篇 |
1984年 | 165篇 |
1983年 | 106篇 |
1982年 | 61篇 |
1981年 | 54篇 |
1979年 | 125篇 |
1978年 | 67篇 |
1977年 | 63篇 |
1976年 | 60篇 |
1975年 | 61篇 |
1974年 | 57篇 |
1973年 | 54篇 |
1971年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Zuo Shogo Sho Masayuki Sawai Toshio Kanehiro Hiromichi Maeda Kosaku Yoshida Makiko Tsukada Ryo Nomura Motonari Okuyama Hiroomi 《Pediatric surgery international》2020,36(2):137-143
Pediatric Surgery International - The programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway has garnered much attention for its roles in clinical oncology. The aim of this study was... 相似文献
4.
5.
6.
Hiroto Kinoshita Hitomi Nishioka Aya Ikeda Kyoko Ikoma Yoichi Sameshima Hidehisa Ohi Mizuki Tatsuno Junka Kouyama Chiaki Kawamoto Tomohiro Mitsui Yuko Tamura Yu Hashimoto Masashi Nishio Tsuyoshi Ogashiwa Yusuke Saigusa Shin Maeda Hideaki Kimura Reiko Kunisaki Kazuhiko Koike 《Journal of gastroenterology and hepatology》2019,34(11):1929-1939
7.
8.
Kei Kamide Yoshihiro Kokubo Hironori Hanada Junko Nagura Jin Yang Shin Takiuchi Chihiro Tanaka Mariko Banno Yoshikazu Miwa Masayoshi Yoshii Tetsutaro Matayoshi Hisayo Yasuda Takeshi Horio Akira Okayama Hitonobu Tomoike Yuhei Kawano Toshiyuki Miyata 《Hypertension research》2006,29(4):243-252
Mutations in the gene encoding 11beta-hydroxysteroid dehydrogenase type 2, HSD11B2, cause a rare monogenic juvenile hypertensive syndrome called apparent mineralocorticoid excess (AME). In AME, defective HSD11B2 enzyme activity results in overstimulation of the mineralocorticoid receptor (MR) by cortisol, causing sodium retention, hypokalemia, and salt-dependent hypertension. Here, we have studied whether genetic variations in HDS11B2 are implicated in essential hypertension in Japanese hypertensives and the general population. By sequencing the entire coding region and the promoter region of HDS11B2 in 953 Japanese hypertensives, we identified five missense mutations in 11 patients (L14F, n = 5; R74H, n = 1; R147H, n = 3; T156I, n = 1; R335H, n = 1) and one novel frameshift mutation (4884Gdel, n = 1) in a heterozygous state, in addition to 19 genetic variations. All genetic variations identified were rare, with minor allele frequencies less than 0.005. Four of 12 patients with the missense/frameshift mutations showed renal failure. Four missense mutations, L14F, R74H, R147H, and R335H, were successfully genotyped in the general population, with a sample size of 3,655 individuals (2,175 normotensives and 1,480 hypertensives). Mutations L14F, R74H, R147H, and R335H were identified in hypertensives (n = 6, 8, 3, and 0, respectively) and normotensives (n = 8, 12, 5, and 0, respectively) with a similar frequency, suggesting that these missense mutations may not strongly affect the etiology of essential hypertension. Since the allele frequency of all of the genetic variations identified in this study was rare, an association study was not conducted. Taken together, our results indicate that missense mutations in HSD11B2 do not substantially contribute to essential hypertension in Japanese. 相似文献
9.
10.
Kengo Maeda Shinji Kume Yoshihiko Nishio Shiro Maeda Yasuhiro Nishida Mikio Suzuki Takahiro Nakaguchi Toru Kawabata Osamu Hashimoto Takashi Hisanaga Atsunori Kashiwagi Hitoshi Yasuda 《Clinical neurology》2006,46(4):266-269
We report a 53-year-old woman with severe Graves' ophthalmopathy accompanied by uncontrolled myasthenia gravis. She presented remarkable exophthalmos, chemosis, and restriction of eye movement. Despite plasma exchange, steroid pulse therapy, local injection of steroid, and irradiation, ocular symptoms did not ameliorate. Since optic neuropathy was seen, orbital decompression surgery was performed in the left eye. Bilateral chemosis was improved after the surgery. Five years after surgery, there was no ocular palsy in the operated left eye, but in the contralateral eye. For the good prognosis of the eye movement, orbital decompression might be recommended in the severe Graves' ophthalmopathy accompanied by the optic neuropathy and/or ophthalmoplegia with proptosis. 相似文献